NRC National Research PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: NRC
- PE Ratio
As of Jul 3, 2025, the NRC stock has a P/E ratio of 16.36. The calculation is based on the latest EPS of $1.04 and the stock price of $17.01 per share. A decrease of 4.2% has been observed in the PE ratio compared to its average of 17.1 of the past four quarters.
NRC PE ratio history
The mean historical PE ratio of National Research over the last ten years is 35.9. The current 16.36 price-to-earnings ratio is 54% less than the historical average. Analyzing the last ten years, NRC's PE ratio reached its highest point in the Sep 2017 quarter at 71.13, with a price of $37.7 and an EPS of $0.53. The Mar 2025 quarter saw the lowest point at 12.31, with a price of $12.8 and an EPS of $1.04.
National Research PE ratio by year
Maximum annual increase: 78.11% in 2017
Maximum annual decrease: -48.88% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 16.8 | -46.5% | $17.64 | $1.05 |
| 2023 | 31.4 | 7.76% | $39.56 | $1.26 |
| 2022 | 29.14 | 3.19% | $37.3 | $1.28 |
| 2021 | 28.24 | -2.25% | $41.52 | $1.47 |
| 2020 | 28.89 | -43.04% | $42.75 | $1.48 |
| 2019 | 50.72 | 43.64% | $65.94 | $1.3 |
| 2018 | 35.31 | -48.88% | $38.14 | $1.08 |
| 2017 | 69.07 | 78.11% | $37.3 | $0.54 |
| 2016 | 38.78 | 1.54% | $19 | $0.49 |
| 2015 | 38.19 | 20.09% | $16.04 | $0.42 |
| 2014 | 31.8 | -37.48% | $13.99 | $0.44 |
| 2013 | 50.86 | 4.16% | $18.82 | $0.37 |
| 2012 | 48.83 | 9.46% | $18.07 | $0.37 |
| 2011 | 44.61 | 68.02% | $12.94 | $0.29 |
| 2010 | 26.55 | 65.42% | $11.42 | $0.43 |
National Research PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 12.31 | -26.73% | $12.8 | $1.04 |
| Dec 2024 | 16.8 | -16.96% | $17.64 | $1.05 |
| Sep 2024 | 20.23 | 6.64% | $22.86 | $1.13 |
| Jun 2024 | 18.97 | -40.14% | $22.95 | $1.21 |
| Mar 2024 | 31.69 | 0.92% | $39.61 | $1.25 |
| Dec 2023 | 31.4 | -17.19% | $39.56 | $1.26 |
| Sep 2023 | 37.92 | 3.72% | $44.37 | $1.17 |
| Jun 2023 | 36.56 | 2.52% | $43.51 | $1.19 |
| Mar 2023 | 35.66 | 22.37% | $43.51 | $1.22 |
| Dec 2022 | 29.14 | 1.78% | $37.3 | $1.28 |
| Sep 2022 | 28.63 | 6.95% | $39.8 | $1.39 |
| Jun 2022 | 26.77 | -2.08% | $38.28 | $1.43 |
| Mar 2022 | 27.34 | -3.19% | $39.65 | $1.45 |
| Dec 2021 | 28.24 | -4.92% | $41.52 | $1.47 |
| Sep 2021 | 29.7 | -8.11% | $42.17 | $1.42 |
NRC Price vs fair value
NRC average PE ratio chart
NRC's current PE ratio is under its 3, 5 and 10-year averages.
NRC PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| NRC National Research Corp | 16.36 | $387.58M |
| NWBO Northwest Biotherapeutics Inc | N/A | $354.25M |
Frequently asked questions
What is National Research's PE ratio?
The price to earnings ratio for NRC stock is 16.36 as of Jul 3, 2025.
What is the 3-year average PE ratio for National Research (NRC)?
Over the last 3 years, the average PE ratio for NRC stock is 27.21.
What is the 5-year average PE ratio for National Research (NRC)?
Over the last 5 years, the average PE ratio for NRC stock is 28.37.
What is the highest PE ratio for NRC?
Over the last ten years, the quarterly PE ratio reached its highest level at 71.13 in the Sep 2017 quarter.
How does the current PE ratio for NRC compare to its historical average?
NRC's current price to earnings ratio is 54% below its 10-year historical average.
How is NRC's PE ratio calculated (National Research PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Jul 3, 2025), National Research's share price is $17.01. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $1.04. Therefore, National Research's price to earnings ratio for today is 16.36. PE RATIO(16.36) = STOCK PRICE($17.01) / TTM EPS($1.04)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.